Danaher Corporation (BVMF:DHER34)

Market Cap	733.17B
Revenue (ttm)	131.55B
Net Income (ttm)	18.70B
Shares Out	n/a
EPS (ttm)	25.82
PE Ratio	39.21
Forward PE	23.49
Dividend	0.16 (0.45%)
Ex-Dividend Date	Jun 26, 2025

Volume	26
Average Volume	2,721
Open	36.40
Previous Close	36.44
Day's Range	35.80 - 36.40
52-Week Range	35.80 - 56.55
Beta	0.78
RSI	32.99
Earnings Date	Oct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DHER34

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD